CORPORATE PRESENTATION January 2025 FORWARD LOOKING STATEMENTS 2 2025 Protara Therapeutics. All Rights Reserved - Do Not Copy or Distribute Statements contained in this presentation regarding matters that are not histori
Monday, January 13, 2025 1 min read
Key Takeaway: CORPORATE PRESENTATION January 2025
TARA - 002 Lyophilized, Inactivated Group A Streptococcus pyogenes
TARA - 002 Non - Muscle Invasive Bladder Cancer
IV CHOLINE CHLORIDE Phospholipid substrate replacement therapy for patients dependent on parenteral support (PS)
TARA - 002 L
Full Press Release Details
CORPORATE PRESENTATION January 2025
TARA - 002 Lyophilized, Inactivated Group A Streptococcus pyogenes
TARA - 002 Non - Muscle Invasive Bladder Cancer
IV CHOLINE CHLORIDE Phospholipid substrate replacement therapy for patients dependent on parenteral support (PS)